Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01891513 · ClinicalTrials.gov registry record
ACE Inhibitors Combined With Exercise for Seniors - Pilot Study
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 104
- Enrollment target
NCT01891513: Completed study, sponsored by University of Florida.
NCT01891513 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01891513 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
The purpose of this study is to compare, when combined with chronic exercise, the effects of perindopril, losartan, and hydrochlorothiazide.
Primary Outcome
Investigators will assess walking speed by asking the participants to walk at their usual pace over a 4 m course. Participants will be instructed to stand with both feet touching the starting line and to start walking after a specific verbal command.
Interventions
- BEHAVIORAL Exercise
- DRUG ACE inhibitor + exercise
- DRUG Thiazide diuretic + exercise
- DRUG Angiotensin receptor blocker + exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-06 |
What the finished NCT01891513 record still lists
NCT01891513 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Exercise is the first listed.
NCT01891513 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01891513 about?
NCT01891513 is a clinical study titled "ACE Inhibitors Combined With Exercise for Seniors - Pilot Study". The purpose of this study is to compare, when combined with chronic exercise, the effects of perindopril, losartan, and hydrochlorothiazide.
What is the current status of trial NCT01891513?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2014-01. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01891513?
The interventions under investigation include: Exercise (BEHAVIORAL), ACE inhibitor + exercise (DRUG), Thiazide diuretic + exercise (DRUG), Angiotensin receptor blocker + exercise (DRUG).
Who is sponsoring clinical trial NCT01891513?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia